Karen M. Dold

Targets for Dioxin: Genes for Plasminogen Activator Inhibitor-2 and Interleukin-1β

Thomas R. Sutter, Karen Guzmán, Karen M. Dold et al. · Science · 1991 · 338 citations

Immunology, Susceptible Cells, Immunotherapy +17

Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors

Stephen T. Davis, Bill Benson, H. Neal Bramson et al. · Science · 2001 · 167 citations

Cdk Inhibitors, Chemoprevention Strategy, Hair Loss +11

Evidence for direct action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on thymic epithelium

William F. Greenlee, Karen M. Dold, Richard D. Irons et al. · Toxicology and Applied Pharmacology · 1985 · 135 citations

Biochemistry, Direct Action, Medicine +4

Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models

I K Dev, Ronna E. Dornsife, Teresa M. Hopper et al. · British Journal of Cancer · 2004 · 43 citations · Full text

Antitumour Efficacy, Pathology, Pharmacotherapy +16

An in vitro model for studying the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin to human thymus

Jon C. Cook, Karen M. Dold, William F. Greenlee · Toxicology and Applied Pharmacology · 1987 · 39 citations

Human Thymus, Biochemistry, Medicine +9